Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
what tier are glp-1 drugs Patients Face New Barriers for Bristol Myers Squibb - packes:1 collection_pain
Bristol Myers Squibb - U.S. FDA Approves Bristol Myers Squibb's Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
95% CI 0.41–0.49)
collection_pain
packes:1
doi: 10.1016/S2213-8587(21)00002-4 24 GrootjenLNUylNEMvan BeijsterveldtIALPDamenLKerkhofGFHokken-KoelegaACS
US$ 29.64
US$ 25.67
US$ 22.86
US$ 27.15
